BioMarin Pharmaceutical | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 74K 1000 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amgen USD 33.58B 45M 2025-03
Bayer EUR 2.52B 0 2024-12
Biogen USD 100K 0 2024-12
BioMarin Pharmaceutical USD 192K 1000 2025-03
Gilead Sciences USD 1000K 0 2024-12
Incyte USD 193K 0 2025-03
Insmed USD 1.79M 6K 2024-12
Ionis Pharmaceuticals USD 159K 1000 2025-03
Moderna USD 38.6K 100 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
PTC Therapeutics USD 77K 1000 2024-12
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
United Therapeutics USD 800K 0 2025-03
Vertex Pharmaceuticals USD 2.6M 0 2024-12



BioMarin Pharmaceutical Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.